Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Laser Photonics Reports Full Year Total Net Sales Increase of 144% in Q4 2025 Financial Results (click to learn more) This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Psyence Group Inc C.PSYG

Alternate Symbol(s):  PSYGF

Healthcare Drug Manufacturers - Major Psychedelics
Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.


CSE:PSYG - Post by User

Psyence Group Inc
Bullboard Posts
Next >>
User Avatar Image
(44)
•••
  • evilballsX
Post by evilballson Jan 29, 2021 1:15am
1124 Views
Post# 32417667

Health Canada License

Health Canada LicenseThis company made an elite group of companies....   they actually havea  health Canada License.
  1. NUMI ....  $200M
  2. MYCO..... $80M
  3. HAVN......  $60M
  4. MCUR...... $40M
  5. PSYG.....  $40M

Those numbers suggest some growing is going to happen.  If you got a Health Canada License they are pretty much following a recetratonal rollout pathway.  I think most of those numbers don't included the recent bought deals which makes HAVN and PSYG look liek absolute steals.  

Tuck this away in the portfolio and check it next time this year.


Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities